Related Experiment Videos
Risk of hypotension during apnea testing
1Department of Neurology, State University of New York Health Science Center at Brooklyn.
Archives of Neurology
|June 1, 1994
Summary
Apnea testing for brain death determination can cause significant hypotension in nearly 40% of patients. Close vital sign monitoring is crucial for safely completing this critical diagnostic procedure.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Apnea testing is a critical component in the clinical diagnosis of brain death.
- Assessing the safety of apnea testing in critically ill patients is essential.
Observation:
- A prospective study evaluated 70 apnea tests in 61 comatose patients at an inner-city trauma center.
- Significant hypotension (>= 15% drop in mean arterial pressure) occurred in 39% of tests.
- Vasopressor support was required in some cases, and 14 tests were aborted due to complications.
Findings:
- Only 61% of apnea tests were well tolerated without significant hemodynamic compromise.
- Hypotension was the primary complication, necessitating interventions or test termination.
- The safety profile indicates potential risks associated with the procedure.
Implications:
- Apnea testing carries a considerable risk of hypotension, impacting patient safety.
- Continuous and vigilant monitoring of vital signs is imperative during apnea testing.
- These findings underscore the need for careful patient selection and management during brain death protocols.